T1	Participants 589 627	4 patients were recruited to the study
T2	Participants 629 692	ten received cyclosporin with blood transfusions (BT) (group 1)
T3	Participants 694 724	14 received BT alone (group 2)
T4	Participants 759 785	3 of 9 patients in group 1
T5	Participants 790 819	8 of 12 patients in group 2 (
T6	Participants 889 913	9 of 9 patients in group
T7	Participants 920 947	7 of 12 patients in group 2
